ES2706875T3 - Polimorfos de acilsulfonamidas - Google Patents

Polimorfos de acilsulfonamidas Download PDF

Info

Publication number
ES2706875T3
ES2706875T3 ES09782376T ES09782376T ES2706875T3 ES 2706875 T3 ES2706875 T3 ES 2706875T3 ES 09782376 T ES09782376 T ES 09782376T ES 09782376 T ES09782376 T ES 09782376T ES 2706875 T3 ES2706875 T3 ES 2706875T3
Authority
ES
Spain
Prior art keywords
compound
acid
hiv
powder
polymorphic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09782376T
Other languages
English (en)
Spanish (es)
Inventor
James Prentice Davidson
Michael Martin
Fei Pang
Margaret Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2706875T3 publication Critical patent/ES2706875T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51—Y being a hydrogen or a carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/42—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ES09782376T 2008-09-09 2009-08-31 Polimorfos de acilsulfonamidas Active ES2706875T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9536408P 2008-09-09 2008-09-09
PCT/EP2009/061185 WO2010028968A2 (en) 2008-09-09 2009-08-31 Polymorphs of acyl sulfonamides

Publications (1)

Publication Number Publication Date
ES2706875T3 true ES2706875T3 (es) 2019-04-01

Family

ID=41664548

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09782376T Active ES2706875T3 (es) 2008-09-09 2009-08-31 Polimorfos de acilsulfonamidas

Country Status (16)

Country Link
US (1) US8063103B2 (enExample)
EP (1) EP2334638B1 (enExample)
JP (6) JP5989339B2 (enExample)
KR (7) KR20180001582A (enExample)
CN (1) CN102143943B (enExample)
AU (1) AU2009290988B2 (enExample)
BR (3) BRPI0918526B1 (enExample)
CA (5) CA2949912C (enExample)
EA (1) EA019340B1 (enExample)
ES (1) ES2706875T3 (enExample)
IL (4) IL299322B2 (enExample)
MX (1) MX2011002319A (enExample)
PL (1) PL2334638T3 (enExample)
TR (1) TR201818979T4 (enExample)
UA (1) UA107561C2 (enExample)
WO (1) WO2010028968A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2644156C1 (ru) 2017-02-28 2018-02-08 Александр Васильевич Иващенко Пролекарство ингибитора NS5B HCV полимеразы, способ его получения и применения
RU2665383C9 (ru) * 2017-06-22 2019-07-23 Общество с ограниченной ответственностью "Вириом" Фармацевтическая наносуспензия для терапии ВИЧ-инфекции
RU2662160C9 (ru) 2017-07-03 2018-10-22 Александрович Иващенко Андрей Комбинированный лекарственный препарат для терапии вирусных инфекций
RU2716257C1 (ru) * 2019-04-30 2020-03-11 Андрей Александрович Иващенко Активный компонент, фармацевтическая композиция и лекарственный препарат для терапии ВИЧ и СПИДа
RU2717101C1 (ru) 2019-06-03 2020-03-18 Андрей Александрович Иващенко Анелированные 9-гидрокси-1,8-диоксо-1,3,4,8-тетрагидро-2Н-пиридо[1,2-a]пиразин-7-карбоксамиды - ингибиторы интегразы ВИЧ, способы их получения и применения

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100519870B1 (ko) * 1997-01-23 2005-10-12 아스텔라스세이야쿠 가부시키가이샤 신규한 아미드 유도체 및 이를 함유하는 약제학적 조성물
US7166738B2 (en) * 2004-04-23 2007-01-23 Roche Palo Alto Llc Non-nucleoside reverse transcriptase inhibitors
US7625949B2 (en) * 2004-04-23 2009-12-01 Roche Palo Alto Llc Methods for treating retroviral infections
MXPA06012252A (es) * 2004-04-23 2006-12-15 Hoffmann La Roche Compuestos no nucleosidos que inhiben la transcriptasa inversa.
US7618981B2 (en) * 2004-05-06 2009-11-17 Cytokinetics, Inc. Imidazopyridinyl-benzamide anti-cancer agents
MX2007010978A (es) * 2005-04-28 2007-09-19 Pfizer Ltd Derivados de aminoacidos.
WO2007045573A1 (en) * 2005-10-19 2007-04-26 F. Hoffmann-La Roche Ag Phenyl-acetamide nnrt inhibitors
KR20100092424A (ko) * 2007-07-30 2010-08-20 아디아 바이오사이언스즈 인크. 다형체를 포함하는, ｍｅｋ의 억제제로서의 ｎ-(아릴아미노) 술폰아미드의 유도체 및 조성물, 사용 방법 및 이의 제조 방법
CN101959502A (zh) * 2008-03-04 2011-01-26 弗·哈夫曼-拉罗切有限公司 制备浓缩胶束水溶液的方法

Also Published As

Publication number Publication date
KR20160092049A (ko) 2016-08-03
IL299322B2 (en) 2024-10-01
CN102143943B (zh) 2014-03-12
EA019340B1 (ru) 2014-02-28
EP2334638A2 (en) 2011-06-22
IL211353A0 (en) 2011-05-31
JP5989339B2 (ja) 2016-09-07
US20100063154A1 (en) 2010-03-11
JP6450340B2 (ja) 2019-01-09
TR201818979T4 (tr) 2019-01-21
JP2021176894A (ja) 2021-11-11
CA3059552A1 (en) 2010-03-18
CA3003213C (en) 2021-07-20
CA2949912A1 (en) 2010-03-18
WO2010028968A3 (en) 2010-06-10
WO2010028968A2 (en) 2010-03-18
KR20110053234A (ko) 2011-05-19
KR20210108499A (ko) 2021-09-02
KR20180001582A (ko) 2018-01-04
IL211353A (en) 2016-04-21
JP2023082131A (ja) 2023-06-13
AU2009290988B2 (en) 2016-01-28
KR101822319B1 (ko) 2018-01-25
JP2019194229A (ja) 2019-11-07
CA3086566C (en) 2025-09-02
KR20220120723A (ko) 2022-08-30
IL264118A (en) 2019-02-28
KR102437499B1 (ko) 2022-08-29
BRPI0918526B1 (pt) 2022-02-15
CA3003213A1 (en) 2010-03-18
IL299322B1 (en) 2024-06-01
CA2735192C (en) 2017-02-28
CA2949912C (en) 2019-12-03
JP2016172741A (ja) 2016-09-29
IL244350A0 (en) 2016-05-01
IL299322A (en) 2023-02-01
BR122021020474B1 (pt) 2022-06-07
CA3059552C (en) 2021-03-16
KR102560207B1 (ko) 2023-07-27
UA107561C2 (xx) 2015-01-26
JP2018058862A (ja) 2018-04-12
US8063103B2 (en) 2011-11-22
EP2334638B1 (en) 2018-11-21
KR20230113420A (ko) 2023-07-28
JP2012502075A (ja) 2012-01-26
BRPI0918526A2 (pt) 2015-12-01
PL2334638T3 (pl) 2019-04-30
CA3086566A1 (en) 2010-03-18
CN102143943A (zh) 2011-08-03
KR101678700B1 (ko) 2016-11-22
EA201100451A1 (ru) 2011-10-31
KR20180110237A (ko) 2018-10-08
AU2009290988A1 (en) 2010-03-18
CA2735192A1 (en) 2010-03-18
MX2011002319A (es) 2011-04-05
BR122021020475B1 (pt) 2022-06-07

Similar Documents

Publication Publication Date Title
JP4627315B2 (ja) 非ヌクレオシド逆転写酵素阻害剤としてのベンジルピリダジノン誘導体
JP2023082131A (ja) アシルスルホンアミドの多形体
ES2391461T3 (es) Compuestos de benciltriazolona utilizados como inhibidores no nucleósidos de transcriptasa inversa